Growth Metrics

GeneDx Holdings (WGS) Receivables - Net (2020 - 2025)

Historic Receivables - Net for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $60.9 million.

  • GeneDx Holdings' Receivables - Net rose 5944.01% to $60.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.9 million, marking a year-over-year increase of 5944.01%. This contributed to the annual value of $37.6 million for FY2024, which is 1624.29% up from last year.
  • Latest data reveals that GeneDx Holdings reported Receivables - Net of $60.9 million as of Q3 2025, which was up 5944.01% from $48.0 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Receivables - Net high stood at $60.9 million for Q3 2025, and its period low was $21.3 million during Q3 2021.
  • Over the past 5 years, GeneDx Holdings' median Receivables - Net value was $33.3 million (recorded in 2021), while the average stood at $36.3 million.
  • As far as peak fluctuations go, GeneDx Holdings' Receivables - Net skyrocketed by 10072.92% in 2022, and later crashed by 2858.55% in 2023.
  • Over the past 5 years, GeneDx Holdings' Receivables - Net (Quarter) stood at $26.5 million in 2021, then surged by 60.83% to $42.6 million in 2022, then decreased by 24.07% to $32.4 million in 2023, then grew by 16.24% to $37.6 million in 2024, then surged by 61.94% to $60.9 million in 2025.
  • Its Receivables - Net stands at $60.9 million for Q3 2025, versus $48.0 million for Q2 2025 and $46.0 million for Q1 2025.